Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 ICON Acquires MolecularMD | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

ICON Acquires MolecularMD

Deal brings to ICON expanded testing platforms, including next generation sequencing, and immunohistochemistry (IHC)

By: Betsy Louda

, Contract Pharma

ICON plc has acquired MolecularMD, a molecular diagnostic specialty laboratory focused on the development and commercialization of precision medicines in oncology. 

 
The acquisition enhances ICON’s laboratory offering in molecular diagnostic testing and brings to ICON expanded testing platforms, including next generation sequencing, and immunohistochemistry (IHC).

“We are delighted to be joining ICON,” said Dan Snyder, president, MolecularMD. “Together with ICON, we can offer clients broader clinical trial and scientific expertise, more comprehensive testing capabilities and global scale to help them accelerate development timelines and reduce costs. We remain committed to providing agile clinical trial assay development across technology platforms and extending all the way through regulatory approval and commercialization of companion diagnostics.”

Steve Cutler, chief executive officer, ICON, said, “We are committed to expanding the testing we offer into specialized areas so that we can help customers to take time and cost from the development and commercialization of precision medicines. MolecularMD enhances our laboratory offering in molecular diagnostic testing, a key area in oncology research, and brings to ICON expanded testing platforms and diagnostic services. They have a strong reputation for innovation and quality and are a great addition to the ICON team.” 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters